Introduction to Merck Globally and in China
Merck is a leading science and technology company focused on three areas: Healthcare, Life Science, and Performance Materials. Around 57,000 employees worldwide serve Merck, driving technological progress and improving people's lives, from biotherapies for cancer and multiple sclerosis to cutting-edge solutions for scientific research and manufacturing, to liquid crystal materials for smartphones and flat-screen TVs. In 2019, Merck's total sales in 66 countries reached €16.2 billion.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The Merck family, as the company's founders, still holds the majority of Merck's shares, and the company is one of the thirty largest German companies on the Frankfurt Stock Exchange. Merck, based in Darmstadt, Germany, owns the global rights to the name and brand "Merck," with the only exceptions being Canada and the United States, where Merck operates under the names EMD Serono, MilliporeSigma, and EMD Performance Materials.
Merck has a history of 87 years in China, with its first branch in China established in Shanghai as early as 1933.
China is one of Merck's most important strategic countries globally and has become a global innovation hub for Merck. In recent years, Merck's investments in Healthcare and Life Science in Nantong and in Performance Materials in Shanghai reached €170 million, €80 million, and €44 million, respectively. In addition, Merck has established a Global Biopharmaceutical R&D Center in Beijing; in Shanghai, a Display Materials R&D China Center, an Appearance Technology Application Experiment China Center, an OLED Technology China Center, a Life Science Laboratory, and an Asia-Pacific BioReliance® End-to-End Bioprocess Development Center; and in Suzhou, a Lithography Materials R&D China Center.
Every day, Merck China's 4,100 employees are committed to providing high-quality and innovative products and services that have a positive impact on people's lives.
Introduction to Merck Nantong Life Science Center
Currently under construction, the Merck Nantong Life Science Center has a total investment of approximately €80 million and covers an area of about 41,000 square meters (about 62.5 mu). It will further consolidate Merck's leading position in the Chinese biopharmaceutical industry for cell culture media products and related technical services, high-purity inorganic salts, and ready-to-use media. The establishment of this center confirms Merck's confidence in the Chinese market and the ambition of Merck's Life Science business's three business units—Science, Applications, and Process Solutions—to maintain strong growth in China.
In recent years, with the vigorous development of China's pharmaceutical market and its important position in the global market, Merck's Life Science business will provide leading innovative products and services to the biopharmaceutical and life science industries to support the rapid development of the industry. The main product types provided include: high-purity inorganic salts (APIs, excipients, food additives), cell culture media, culture media, and prepared microbiological testing devices. The factory is located at No. 39 Jianggang Road, Nantong Economic and Technological Development Area.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows